1173 related articles for article (PubMed ID: 18194186)
1. The role of BPH, lower urinary tract symptoms, and PSA levels on erectile function of Brazilian men who undergo prostate cancer screening.
Antunes AA; Srougi M; Dall'oglio MF; Vicentini F; Paranhos M; Freire GC
J Sex Med; 2008 Jul; 5(7):1702-7. PubMed ID: 18194186
[TBL] [Abstract][Full Text] [Related]
2. The prevalence of erectile dysfunction among Brazilian men screened for prostate cancer.
Paranhos M; Antunes A; Andrade E; Freire G; Srougi M
BJU Int; 2009 Oct; 104(8):1130-3. PubMed ID: 19426190
[TBL] [Abstract][Full Text] [Related]
3. The relationship among lower urinary tract symptoms, prostate specific antigen and erectile dysfunction in men with benign prostatic hyperplasia: results from the proscar long-term efficacy and safety study.
Paick SH; Meehan A; Lee M; Penson DF; Wessells H
J Urol; 2005 Mar; 173(3):903-7. PubMed ID: 15711315
[TBL] [Abstract][Full Text] [Related]
4. A new experimental rat model of erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: the testosterone-supplemented spontaneously hypertensive rat.
Oudot A; Oger S; Behr-Roussel D; Caisey S; Bernabé J; Alexandre L; Giuliano F
BJU Int; 2012 Nov; 110(9):1352-8. PubMed ID: 22448674
[TBL] [Abstract][Full Text] [Related]
5. The associations among eNOS G894T gene polymorphism, erectile dysfunction, and benign prostate hyperplasia-related lower urinary tract symptoms.
Lee YC; Wu WJ; Liu CC; Wang CJ; Li WM; Huang CH; Yeh HC; Ke HL; Huang SP
J Sex Med; 2009 Nov; 6(11):3158-65. PubMed ID: 19515207
[TBL] [Abstract][Full Text] [Related]
6. Insulin resistance is an independent predictor of severe lower urinary tract symptoms and of erectile dysfunction: results from a cross-sectional study.
Russo GI; Cimino S; Fragalà E; Privitera S; La Vignera S; Condorelli R; Calogero AE; Castelli T; Favilla V; Morgia G
J Sex Med; 2014 Aug; 11(8):2074-82. PubMed ID: 24836928
[TBL] [Abstract][Full Text] [Related]
7. Correlation between lower urinary tract symptoms and erectile dysfunction in men presenting for prostate cancer screening.
Reggio E; de Bessa J; Junqueira RG; Timm O; Sette MJ; Sansana V; Gomes CM
Int J Impot Res; 2007; 19(5):492-5. PubMed ID: 17554395
[TBL] [Abstract][Full Text] [Related]
8. Effects of tadalafil on lower urinary tract symptoms secondary to benign prostatic hyperplasia and on erectile dysfunction in sexually active men with both conditions: analyses of pooled data from four randomized, placebo-controlled tadalafil clinical studies.
Porst H; Roehrborn CG; Secrest RJ; Esler A; Viktrup L
J Sex Med; 2013 Aug; 10(8):2044-52. PubMed ID: 23782459
[TBL] [Abstract][Full Text] [Related]
9. The relationship between lower urinary tract symptoms (LUTS), diagnostic indicators of benign prostatic hyperplasia (BPH), and erectile dysfunction in patients with moderate to severely symptomatic BPH.
Ozayar A; Zumrutbas AE; Yaman O
Int Urol Nephrol; 2008; 40(4):933-9. PubMed ID: 18437522
[TBL] [Abstract][Full Text] [Related]
10. Benign prostatic hyperplasia (BPH) and prostatitis: prevalence of painful ejaculation in men with clinical BPH.
Nickel JC; Elhilali M; Vallancien G;
BJU Int; 2005 Mar; 95(4):571-4. PubMed ID: 15705082
[TBL] [Abstract][Full Text] [Related]
11. Association of lower urinary tract symptom/benign prostatic hyperplasia measures with international index of erectile function 5 in middle-aged policemen of Korea and the role of metabolic syndrome and testosterone in their relationship.
Lee JH; Kwon H; Park YW
Urology; 2013 Nov; 82(5):1008-12. PubMed ID: 24041675
[TBL] [Abstract][Full Text] [Related]
12. Association between erectile dysfunction and lower urinary tract symptoms due to benign prostatic hyperplasia in Nigerian men.
Ikuerowo SO; Akindiji YO; Akinoso OA; Akinlusi FM; Esho JO
Urol Int; 2008; 80(3):296-9. PubMed ID: 18480635
[TBL] [Abstract][Full Text] [Related]
13. An Asian multinational prospective observational registry of patients with benign prostatic hyperplasia, with a focus on comorbidities, lower urinary tract symptoms and sexual function.
Li MK; Garcia L; Patron N; Moh LC; Sundram M; Leungwattanakij S; Pripatnanont C; Cheng C; Chi-Wai M; Loi-Cheong N
BJU Int; 2008 Jan; 101(2):197-202. PubMed ID: 18005205
[TBL] [Abstract][Full Text] [Related]
14. Treatment of lower urinary tract symptoms in benign prostatic hyperplasia and its impact on sexual function.
Miner M; Rosenberg MT; Perelman MA
Clin Ther; 2006 Jan; 28(1):13-25. PubMed ID: 16490576
[TBL] [Abstract][Full Text] [Related]
15. Correlation of Subjective Symptoms in Patients with Benign Prostatic Hyperplasia and Erectile Dysfunction.
Kardasevic A; Milicevic S
Med Arch; 2017 Feb; 71(1):32-36. PubMed ID: 28428671
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of sexual function in men with symptomatic benign prostatic hyperplasia].
Shao Q; Song J; Guo YW; Lu WC; Du LD
Zhonghua Nan Ke Xue; 2005 Jul; 11(7):505-7. PubMed ID: 16078666
[TBL] [Abstract][Full Text] [Related]
17. [Erectile dysfunction in men with lower urinary tract symptoms].
Liang GQ; Zheng JB; Wu M; Li JH; Shen YZ; Wang J; Li YM; Yu JF; Li D; Yu XH; Li Z
Zhonghua Nan Ke Xue; 2014 Feb; 20(2):129-32. PubMed ID: 24520663
[TBL] [Abstract][Full Text] [Related]
18. Erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH) combined responders to tadalafil after 12 weeks of treatment.
Roehrborn CG; Egan KB; Miner MM; Ni X; Wong DG; Rosen RC
BJU Int; 2016 Jul; 118(1):153-60. PubMed ID: 26765325
[TBL] [Abstract][Full Text] [Related]
19. Tadalafil - a therapeutic option in the management of BPH-LUTS.
Carson CC; Rosenberg M; Kissel J; Wong DG
Int J Clin Pract; 2014 Jan; 68(1):94-103. PubMed ID: 24341303
[TBL] [Abstract][Full Text] [Related]
20. [Influences of erectile functions in benign prostatic hyperplasia patients by two micro (thulium) laser resection of prostate-tangerine technique].
Luo GH; Sun ZL; Xia SJ
Zhonghua Yi Xue Za Zhi; 2011 Aug; 91(32):2243-6. PubMed ID: 22094087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
